A comparison of two classes of anticoagulant used to treat HIT
Check mark () indicates favorable feature in comparison of drug classes. Reprinted, with modifications and permission, from Warkentin 2010.30
ACS indicates acute coronary syndrome; INR, International Normalized Ratio.
*For danaparoid, half-lives of its anti-thrombin and its thrombin generation inhibition activities (2-4 h and 3-7 h, respectively) are shorter than for its anti-Xa activity (∼ 25 h).
†Although therapeutic dosing is recommended for HIT, availability of prophylactic-dose regimens increases flexibility when managing potential non-HIT situations.